首页> 美国卫生研究院文献>Diagnostic and Interventional Radiology >Does neoadjuvant doxorubicin drug-eluting bead transarterial chemoembolization improve survival in patients undergoing liver transplant for hepatocellular carcinoma?

【2h】

Does neoadjuvant doxorubicin drug-eluting bead transarterial chemoembolization improve survival in patients undergoing liver transplant for hepatocellular carcinoma?

机译：新辅助药物阿霉素洗脱珠经动脉化学栓塞治疗能否改善肝癌肝移植患者的生存率？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

PURPOSEWe aimed to compare the overall (OS) and disease-free survival (DFS) of patients undergoing orthotopic liver transplant (OLT) for hepatocellular carcinoma who did and did not have neoadjuvant doxorubicin drug-eluting bead transarterial chemoembolization (DEB-TACE).

机译：目的我们旨在比较接受和不接受新辅助阿霉素药物洗脱小珠经动脉化学栓塞术（DEB-TACE）的原位肝移植（OLT）肝细胞癌患者的总体（OS）和无病生存期（DFS）。

著录项

期刊名称 Diagnostic and Interventional Radiology
作者
Dimitri Dorcaratto; Venkatesha Udupa; Niamh M. Hogan; David P. Brophy; Jeffrey W. McCann; Donal Maguire; Justin Geoghegan; Colin P. Cantwell; Emir Hoti;
展开▼
作者单位

展开▼
年(卷),期 2017(23),6
年度 2017
页码 441–447
总页数 7
原文格式 PDF
正文语种
中图分类放射医学;影像诊断学;
关键词

相似文献

外文文献
中文文献
专利

1. mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE) [J] . PrajapatiH.J., SpiveyJ.R., HanishS.I., Annals of oncology: official journal of the European Society for Medical Oncology . 2013,第4期

机译：对比增强动态MRI在早期时间点的mRECIST和EASL反应可预测阿霉素药物洗脱珠经动脉化学栓塞（DEB TACE）治疗的不可切除肝细胞癌（HCC）患者的生存
2. Comparison of Treatment Response and Survival Profiles Between Drug-Eluting Bead Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Chinese Hepatocellular Carcinoma Patients: A Prospective Cohort Study [J] . Wen Ping, Chen Sheng-Duo, Wang Jia-Rui, Oncology Research . 2019,第5期

机译：药物洗脱珠霉变化疗与中国肝细胞癌患者常规龙霉栓塞之间治疗响应和存活谱的比较：临时队列研究
3. Neoadjuvant Transarterial Chemoembolization Improves Survival After Liver Transplant in Patients With Hepatocellular Carcinoma [J] . John D. Werner, Constantine Frangakis, Jessica M. Ruck, Experimental and clinical transplantation . 2019,第5期

机译：新辅助经动脉化学栓塞术可改善肝细胞癌患者肝移植后的生存率
4. Improved quantitative contrast-enhanced ultrasound imaging of hepatocellular carcinoma response to transarterial chemoembolization [C] . Ipek Oezdemir, Collette Shaw, John R. Eisenbrey, IEEE International Symposium on Biomedical Imaging . 2019

机译：改进的肝细胞癌对经动脉化疗栓塞反应的定量对比增强超声成像
5. Sesquiterpene drugs as potential treatment for hepatocellular carcinoma (HCC): Preclinical evaluation of parthenolide administered via transarterial chemoembolization in a rat HCC tumor model. [D] . Chen, Zheng. 2016

机译：倍半萜类药物可作为肝细胞癌（HCC）的潜在治疗方法：在大鼠HCC肿瘤模型中，通过经动脉化学栓塞术施用的小白菊内酯的临床前评估。
6. Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: a preliminary study [O] . Renumathy Dhanasekaran, David A Kooby, Charles A Staley, 2010

机译：接受阿霉素药物洗脱珠化学栓塞的不可切除肝细胞癌患者生存的预后因素：初步研究
7. Abstract No. 518 Comprehensive analysis of treatment response and survival profiles in hepatocellular carcinoma patients: drug-eluting beads transarterial chemoembolization with CalliSpheres microspheres versus conventional transarterial chemoembolization [O] . C. Zheng, H. Xiang, C. Ma 2019

机译：摘要肝细胞癌患者治疗响应和存活谱的综合分析：药物洗脱珠子曲调与愈合球菌微球的曲调化疗与常规曲调化疗栓塞

Does neoadjuvant doxorubicin drug-eluting bead transarterial chemoembolization improve survival in patients undergoing liver transplant for hepatocellular carcinoma?

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅